SOCIAL – ECONOMIC COSTS OF THE IMMUNOLOGICAL TREATMENT OF SEVERE PSORIASIS COMPARED TO THE CLASSIC THERAPY
Abstract:
The economic analysis appreciates both the debit (costs and resources), as well as the credit (reducing mortality, morbidity, increasing longevity, improving life quality) of the patients suffering from psoriasis. The clinical trials carried out with biological therapies show significant improvements of the indexes measuring the diseases severity both from the physical point of view (PASI – Psoriasis Area Severity Index) and from the life quality point of view (DLQI – Dermatological Life Quality Index), indexes that are equally important for the patient. A major issue in applying the biological therapies is the high cost, which is ten times higher than the classical systemic therapies.(1,2).
full text article in Romanian (.RO) |
full text article in English (.EN) |